Venetoclax is a small molecule drug that directly and selectively inhibits the B-cell leukemia/lymphoma 2 (Bcl-2) anti-apoptotic protein [38], highly expressed in many hematologic malignancies, including AML. The gene discussed is BCL2; the disease is acute myeloid leukemia.